PRO#0118: A Phase I Study of Decitabin in Combination With Fludarabin and Busulfan as a Reduced Intensity Conditioning Regimen for the Treatment of Myeloid Malignancies
Latest Information Update: 28 Aug 2018
At a glance
- Drugs Busulfan (Primary) ; Decitabine (Primary) ; Fludarabine (Primary)
- Indications Acute myeloid leukaemia; Transplant rejection
- Focus Therapeutic Use
- Acronyms Decitabine Plus Mini Flu-Bu
- 07 Nov 2012 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov record.
- 26 Oct 2011 New trial record